Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Rare Diseases

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Glioblastoma

INC280

Novartis Pharmaceuticals

This study will assess the safety and efficacy of INC280 in patients with solid tumors that are refractory to current treatment or for which there is not a current standard of care and whose tumors have dysregulation of the c-MET pathway.

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors	NCT01324479	Solid Tumors	INC280	18 Years -	Novartis
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors	NCT01324479	Solid Tumors	INC280	18 Years -	Novartis

Spots Global Cancer Trial Database for breast,

Every month we try and update this database with for breast, cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for breast,

Every month we try and update this database with for breast, cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for breast, cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.